Interestingly, TGF-β1 is capable of inhibiting IL-1β and IL-6-induced CRP production in a time and dosage-dependent manner34, suggesting a regulatory loop between CRP and TGF-β in renal fibrosis and inflammation. This evidence concerns the gene IL6 and renal fibrosis.